ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis
January 29, 2022Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today reports that the first patients have been enrolled in a Phase III clinical study using AKP02 cutaneous spray... -
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis
April 23, 2021Lipidor AB (publ) provides an update on the planned Phase III study of the company's drug candidate AKP02 for the treatment of psoriasis. During the first quarter of 2021, Lipidor submitted an application to the Indian Medical Products Agency for ...
Pharma Sources Insight January 2025
